Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €0.49 EUR
Change Today -0.011 / -2.21%
Volume 0.0
MSK On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 2:20 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

microport scientific corp (MSK) Snapshot

Open
€0.49
Previous Close
€0.50
Day High
€0.49
Day Low
€0.49
52 Week High
04/13/15 - €0.56
52 Week Low
12/22/14 - €0.32
Market Cap
691.2M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
1.4B
EX-Date
06/29/15
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MICROPORT SCIENTIFIC CORP (MSK)

Related News

No related news articles were found.

microport scientific corp (MSK) Related Businessweek News

No Related Businessweek News Found

microport scientific corp (MSK) Details

MicroPort Scientific Corporation, an investment holding company, develops, manufactures, exports, and sells interventional medical devices worldwide. Its Orthopedic Devices segment offers orthopedic products of artificial joints, spinal products, trauma products, sport medicine, and other instruments and implants. This segment’s product line includes Superpath micro posterior approach total hip reconstruction technique, Biofoamtm Cancellous Titaniumtm, Evolution medial pivot knee system, Prophecy pre-operative navigation guiding system, and REPIPHYSIS oncology auto-expandable endoprosthesis. The company’s Cardiovascular Devices segment provides coronary stents and related delivery systems; and balloon catheters and accessories. Its Endovascular Devices segment provides AAA/TAA stent graft systems, Hercules balloon dilation catheters, surgical stent graft systems, and peripheral stent systems to treat abdominal and thoracic aortic aneurysms, and peripheral vascular diseases. The company’s Electrophysiological Devices segment offers minimally invasive medical devices, such as FireMagic, EasyFinder, EasyLoop, FireMagic 3D, Columbus, and external reference patch for the treatment of electrophysiological diseases. Its Neurovascular Devices segment provides medical devices to treat the central nervous system related vascular diseases. This segment’s products include WILLIS, an intracranial stent graft system for the treatment of intracranial aneurysms. The company’s Surgical Management segment offers extracorporeal circulation and cardiovascular-related devices, such as membrane oxygenation system, Amender PDA Occluder, and Amender ASD Occluder. Its Diabetes Care and Endocrinal Management segment develops, manufactures, monitors, and manages medical devices, which primarily include La Fenice insulin pump and La Fenice hypophyseal hormone infusion pump for the treatment of diabetes and endocrinal. The company was founded in 1998 and is headquartered in Shanghai, China.

2,903 Employees
Last Reported Date: 04/22/15
Founded in 1998

microport scientific corp (MSK) Top Compensated Officers

Founder, Chairman of the Board, Chief Executi...
Total Annual Compensation: $98.0K
Compensation as of Fiscal Year 2014.

microport scientific corp (MSK) Key Developments

MicroPort Scientific Corporation Reports Audited Consolidated Cash Flow Results for the Year Ended December 31, 2014

MicroPort Scientific Corporation reported audited consolidated cash flow results for the year ended December 31, 2014. For the period, the company has posted net cash generated from operating activities of $17,806,000 against $57,753,000 a year ago.

Microport Scientific Corporation Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

MicroPort Scientific Corporation reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company's turnover was $355,284,000 compared to $151,655,000 a year ago. Such increase was primarily attributable to the increase of the sales of orthopedics devices arising from the acquisition of the OrthoRecon business. Loss from operations was $39,366,000 compared to profit from operations of 34,217,000 a year ago. Loss before taxation was $53,514,000 compared to profit before taxation of $33,162,000 a year ago. Loss for the year was $59,571,000 compared to profit of $23,997,000 a year ago. Loss attributable to equity shareholders of the Company was $59,461,000 compared to profit attributable to equity shareholders of the Company of $23,997,000 a year ago. Such decrease was primarily due to the consolidation of the newly acquired OrthoRecon business which incurred a net loss of $54.2 million, including transaction and transitional expenses of $10.4 million, goodwill impairment of $23.3 million for the year ended 31 December 2014 and interest expense of $13.0 million for the year ended 31 December 2014 for the interest-bearing borrowings made and the convertible bonds issued for the payment of the acquisition of the OrthoRecon business. Excluding the impacts, the remaining business of the Group recorded a net profit of $30.9 million for the year ended 31 December 2014. Diluted loss per share was 4.27 cents compared to earnings of 1.67 cents a year ago. In addition, during the year, the Group's total capital expenditure amounted to approximately $62.1 million, which was used in construction of building, acquiring equipment and machinery and capitalisation of R&D projects expenses.

MicroPort Scientific Corporation, 2014 Earnings Call, Apr 02, 2015

MicroPort Scientific Corporation, 2014 Earnings Call, Apr 02, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSK:GR €0.49 EUR -0.011

MSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MSK.
View Industry Companies
 

Industry Analysis

MSK

Industry Average

Valuation MSK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.2x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MICROPORT SCIENTIFIC CORP, please visit www.microport.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.